Pharvaris holder plans $10.5M sale of 300K shares

A Rule 144 notice covers proposed sales of 300,000 Pharvaris N.V. common shares as founder stock plus earlier three-month sales disclosures.

Rhea-AI Filing Summary

Pharvaris N.V. (PHVS) is the issuer of common shares covered by a notice of proposed sale filed for the account of SCHOODIC MANAGEMENT under Rule 144. The notice lists plans to sell 300,000 common shares through Morgan Stanley Smith Barney LLC Executive Financial Services with an aggregate market value of $10,500,000.00 based on the reported market price. The shares are described as Founder Stock originally acquired from the issuer for cash on November 26, 2015. The notice also reports prior sales during the past three months totaling 6,875 common shares by Berndt Axel Edward Modig on July 13, 2026, August 14, 2026, and September 14, 2026.

Key Figures

Shares to be sold: 300,000 shares Aggregate market value: $10,500,000.00 Shares sold July 13, 2026: 2,292 shares +5 more

8 metrics

Shares to be sold 300,000 shares Common shares of Pharvaris N.V. proposed for sale under Rule 144 for SCHOODIC MANAGEMENT

Aggregate market value $10,500,000.00 Reported market value of 300,000 common shares proposed to be sold

Shares sold July 13, 2026 2,292 shares Common shares sold by Berndt Axel Edward Modig on July 13, 2026

Proceeds July 13, 2026 sale $80,151.24 Value of 2,292 common shares sold by Berndt Axel Edward Modig on July 13, 2026

Shares sold August 14, 2026 2,292 shares Common shares sold by Berndt Axel Edward Modig on August 14, 2026

Proceeds August 14, 2026 sale $79,692.84 Value of 2,292 common shares sold by Berndt Axel Edward Modig on August 14, 2026

Shares sold September 14, 2026 2,291 shares Common shares sold by Berndt Axel Edward Modig on September 14, 2026

Proceeds September 14, 2026 sale $90,265.40 Value of 2,291 common shares sold by Berndt Axel Edward Modig on September 14, 2026

Key Terms

Rule 144, Founder Stock, aggregate market value

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Founder Stock financial

"Common | 11/26/2015 | Founder Stock | Issuer"

aggregate market value financial

"300000 | 10500000.00 | 65210590 | 09/17/2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Pharvaris N.V. (PHVS)?

The filing discloses a planned sale under Rule 144 for the account of SCHOODIC MANAGEMENT of 300,000 Pharvaris N.V. common shares described as founder stock, with a reported aggregate market value of $10,500,000.00 based on the referenced market price.

How many Pharvaris N.V. (PHVS) shares are proposed to be sold under this Form 144?

The notice lists a proposed sale of 300,000 common shares of Pharvaris N.V. for the account of SCHOODIC MANAGEMENT. These shares are identified as Founder Stock acquired from the issuer for cash on November 26, 2015.

What is the reported aggregate market value of the Pharvaris N.V. (PHVS) shares in this Form 144?

The filing reports an aggregate market value of $10,500,000.00 for the 300,000 common shares of Pharvaris N.V. proposed to be sold, based on the market information shown in the securities information section.

Which broker is listed for the proposed Pharvaris N.V. (PHVS) share sales?

The proposed sale of Pharvaris N.V. shares is listed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, in the securities information section of the notice.

What prior sales of Pharvaris N.V. (PHVS) shares are disclosed in the last three months?

The notice reports prior sales by Berndt Axel Edward Modig of Pharvaris N.V. common shares: 2,292 shares for $80,151.24 on July 13, 2026, 2,292 shares for $79,692.84 on August 14, 2026, and 2,291 shares for $90,265.40 on September 14, 2026.

When were the Pharvaris N.V. (PHVS) founder shares originally acquired?

The 300,000 founder shares of Pharvaris N.V. covered by the planned Rule 144 sale are reported as acquired on November 26, 2015 from the issuer for cash, according to the securities to be sold section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 05:27 PM Accepted by SEC EDGAR 09/17/2026 - 05:27 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001643072
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PHARVARIS N.V.
SEC File Number	001-40010
Address of Issuer	Emmy Noetherweg 2 Leiden NETHERLANDS 2333 BK
Phone	31 (0)71 2036 410
Name of Person for Whose Account the Securities are To Be Sold	SCHOODIC MANAGEMENT BV
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	300000	10500000.00	65210590	09/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/26/2015	Founder Stock	Issuer			300000	11/26/2015	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Berndt Axel Edward Modig Emmy Noetherweg 2 Leiden P7 2333 BK	Common	09/14/2026	2291	90265.40
Berndt Axel Edward Modig Emmy Noetherweg 2 Leiden P7 2333 BK	Common	08/14/2026	2292	79692.84
Berndt Axel Edward Modig Emmy Noetherweg 2 Leiden P7 2333 BK	Common	07/13/2026	2292	80151.24

144: Remarks and Signature

Remarks
Date of Notice	09/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Berndt Axel Eduard Modig
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)